Pr. Jacques Touchon

He was Dean of the School of Medicine from 2000 to 2010; the Chief of Neurology at the Montpellier University Research Hospital overseeing the entire neurology department.

Co-Chairman of Clinical Trials on Alzheimer disease.

Co-Editor of Journal of Prevention of Alzheimer’s disease.

Pr. Serge Gauthier

Etudes médicales à l’Université de Montréal, résidence en Neurologie à l’Université McGill, stage de recherche au laboratoire du Prof. Theodore L. Sourkes, Allen Memorial Institute, Montréal.

Plein temps géographique à l’Hôpital Neurologique de Montréal, puis directeur du Centre McGill d’Etudes sur le Vieillissement, et titulaire d’une Chaire de recherche du programme des Instituts Canadiens pour la Recherche en Santé et du Rx&D. Professeur titulaire aux départements de neurologie & neurochirurgie, de psychiatrie, de médicine, à l’Université McGill. Membre de l’Ordre du Canada.

Les contributions à la recherche incluent préparation des devis et exécutions d’essais cliniques randomisés, en vue d’établir l’efficacité et la sécurité d’emploi des inhibiteurs de l’acetylcholinesterase, de la mémantine et de molécules pouvant modifier la progression de la maladie d’Alzheimer.

Intérêt particulier pour une approche consensuelle pour la prise en charge de la démence aux divers stades, pour l’éthique de la recherche impliquant des personnes vulnérables, et la prévention primaire des pertes cognitives associées au vieillissement.

Pr. Guy Rouleau

Over the last 25 years, Dr. Guy Rouleau and his team have focused on identifying the genes causing several neurological and psychiatric diseases, including autism, amyotrophic lateral sclerosis, hereditary neuropathies, epilepsy and schizophrenia, as well as providing a better understanding of the molecular mechanisms that lead to these disease symptoms. Among Dr. Rouleau’s main achievements are his

contribution to the identification of dozens of disease-causing genes and his discovery of new mutational mechanisms. Dr. Rouleau has published over 700 articles in peer-reviewed journals and has been quoted more than 50 000 times. He has supervised nearly a hundred students at the Masters, PhD and Post-doctoral levels in addition to receiving numerous awards for his contribution to science and society.

 Pr. Claudio Cuello

Professor Cuello has been trained at the Universities of Buenos Aires (UBA, Argentina), U. C. San Francisco (USA) and Cambridge (England). He held research and academic positions in the  Department of Cell Biology at UBA and in the Department of Pharmacology at both Cambridge and Oxford. He is a past Chair of the McGill Department of Pharmacology and Therapeutics and  presently holds the Charles E. Frosst Merck Chair within the same Department. He is also  currently an Associate Member of the Departments of Anatomy and Cell Biology and Neurology  and Neurosurgery at McGill University, adjunct Professor of the Scripps Institute (LaJolla) and  Visiting Professor at Oxford University. In 2010, Professor Cuello received the Order of Canada.

Professor Cuello’s lab is interested in degenerative and regenerative processes in the CNS with particular emphasis on aging and Alzheimer’s disease (AD) related studies. His lab utilizes and develops transgenic animal models presenting features of the AD neuropathology. The research is of a multidisciplinary nature ranging from molecular approaches to whole animal experimentation and with a particular interest in Alzheimer’s Therapeutics.


Pr. Gerald Batist

Dr. Gerald Batist is the former Chairman of the Department of Oncology at McGill University and Director of the McGill Centre for Translational Research in Cancer. A major award from the Canadian Foundation for Innovation led to the expansion of the Centre and it’s integration into the Segal Cancer Centre at the Jewish General Hospital, which he also directs.  

Dr. Batist is a clinician-scientist, trained in medical oncology and molecular pharmacology. His work, both in his lab and clinical research focuses on therapeutic resistance. This includes large consortia of biopsy-based clinical trials. In 2014 he co-led a successful application that resulted in the establishment of the Canadian National Centre of Excellence in Personalized Medicine, Exactis Innovations. The core feature is a program to build a massive bio bank and database linked to a prospective longitudinal registry of cancer patients followed throughout the trajectory of their illness, a project called ‘Personalize My Treatment’. In 2016, Dr Batist was appointed Member of the Order of Canada and Knight of the National Order of Quebec.

Nuclear Physics

Pr. Thomas Zemb

Professor at INSTN (Institut des Sciences et Techniques Nucléaires).

Deputy director of the Institute for Separation Chemistry in Marcoule.